Risk Factors Associated with Development of Disseminated Intravascular Coagulation (DIC) in Obstetrical Cases

S Munira1, S Hossain, H Siddiqui

  • 1Dr Sirajum Munira, Medical Officer, Dhaka Medical College and Hospital, Dhaka, Bangladesh;

Insights

Disseminated intravascular coagulation (DIC) in pregnancy is a major cause of maternal mortality. Key risk factors include abruptio placenta, postpartum hemorrhage, and preeclampsia, highlighting the need for rapid identification and management.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Critical Care Medicine

Background:

  • Disseminated intravascular coagulation (DIC) is a life-threatening condition with high maternal mortality rates globally.
  • In pregnancy, DIC is a critical obstetric emergency, often stemming from coagulation cascade overactivation leading to microvascular thrombosis and organ dysfunction.
  • Also known as consumption coagulopathy, DIC presents as severe bleeding disorders.

Purpose of the Study:

  • To investigate the specific obstetrical risk factors contributing to the development of DIC in pregnant women.
  • To identify common clinical presentations and outcomes associated with DIC in an obstetric population.

Main Methods:

  • A descriptive, cross-sectional study involving 300 pregnant women diagnosed with DIC at Dhaka Medical College Hospital from January 2020 to December 2022.
  • Data collection included detailed patient history, clinical examinations, and relevant investigations to identify obstetrical risk factors.
  • Statistical analysis was performed using SPSS version 22.0.

Main Results:

  • Abruptio placenta (34.0%), postpartum hemorrhage (PPH) (27.0%), and preeclampsia/eclampsia (22.0%) were significant risk factors for DIC.
  • Hypertension (72.0%), antepartum hemorrhage (45.3%), and PPH (38.7%) were frequently observed comorbidities.
  • Maternal mortality was 12.0% and perinatal mortality was 24.3%.

Conclusions:

  • Obstetrical complications such as abruptio placenta, PPH, and hypertensive disorders are major drivers of DIC in pregnancy.
  • High rates of maternal and perinatal mortality underscore the severity of DIC in obstetric cases.
  • Prompt recognition and effective management strategies are crucial for improving outcomes in pregnant women with DIC.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
695
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
382
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K